RSS
Home
Business and Finance
Business News
Military sees increase in wounded in Afghanistan- Far from winding down, the numbers of wounded U.S. soldiers coming home have continued to swell. The problem is especially acute among those who fought in Afghanistan, where nearly four times as many troops were injured in October as a year ago.
Who knew of Fort Hood suspect's radical contacts?- The mystery over whether the military knew Fort Hood shooting suspect Nidal Hasan was communicating with a radical Muslim imam lapsed into finger-pointing ahead of congressional investigations looking into the Army psychiatrist's contacts with any extremists.
Bomb kills 9 security officers in Pakistan- Officials say a roadside bomb has killed nine security officers in a Pakistani region close to the Afghan border.
AP-GfK Poll: A grouchy public sticking with Obama- President Barack Obama still has the approval of a majority of Americans, but it's an increasingly pessimistic nation.
- Military divers have found the body of one of two U.S. soldiers who went missing last week as they tried to recover airdropped supplies that fell into a river in western Afghanistan, NATO said Wednesday.
Lights back in Brazil after outage hits up to 60M- Brazil emerged early Wednesday from a widespread power outage that plunged as many as 60 million people in at least nine states into darkness for hours, prompting security fears and concern from residents about another black eye for a country hosting the 2016 Olympic Games.
Swift wins 2nd straight BMI award for top song- Taylor Swift started what could be an interesting week with her second straight song of the year award at the BMI Country Awards Tuesday, when Kris Kristofferson was honored as an icon.
Tiger will face tricky test at the Kingston Heath- The sun-baked fans let out a cheer Wednesday when Tiger Woods pulled his driver from the bag, a rarity at the Australian Masters on the shortest golf course he has played all year.
Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
MOUNTAIN VIEW, Calif.
(Map)
-
Prior to his tenure at Telik, Mr. Parra was a Principal Partner at West
Coast Associates from
"We are very pleased to welcome Carlos to Alexza to lead our Quality Departments and as a member of our Management Team," said
About Alexza Pharmaceuticals
Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.
Alexza has six product candidates in clinical development. Alexza's lead
program, AZ-004 (Staccato loxapine) for the treatment of acute agitation in
schizophrenic or bipolar disorder patients, is in Phase 3 testing. AZ-001
(Staccato prochlorperazine) for the acute treatment of migraine headaches has
completed Phase 2 testing. AZ-104 (Staccato loxapine) for the acute treatment
of migraine headaches and AZ-002 (Staccato alprazolam) for the acute treatment
of panic attacks associated with panic disorder are in Phase 2 testing.
Product candidates in Phase 1 testing include AZ-003 (Staccato fentanyl) for
the treatment of breakthrough pain, which is partnered with Endo
Pharmaceuticals in
|
|
